{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T22:58:43Z","timestamp":1784156323539,"version":"3.55.0"},"reference-count":20,"publisher":"Japan Atherosclerosis Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.5551\/jat.45583","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T22:33:08Z","timestamp":1543876388000},"page":"559-572","source":"Crossref","is-referenced-by-count":9,"title":["Investigation into Lipid Management in Acute Coronary Syndrome Patients from the EXPLORE-J Study"],"prefix":"10.5551","volume":"26","author":[{"given":"Masato","family":"Nakamura","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Toho University Ohashi Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Ako","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kitasato University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, National Center for Geriatrics and Gerontology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hirayama","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, Osaka Police Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, Toho University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Nohara","sequence":"additional","affiliation":[{"name":"Department of Lipidology, Kanazawa University of Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoko","family":"Uno","sequence":"additional","affiliation":[{"name":"Cardiovascular Medical, Diabetes & Cardiovascular Medical Operations, Sanofi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuka","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Cardiovascular Medical, Diabetes & Cardiovascular Medical Operations, Sanofi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Harada-Shiba","sequence":"additional","affiliation":[{"name":"Department of Molecular Innovation in Lipidology, National Cerebral & Cardiovascular Center Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists\u2019 (CTT) Collaborators: Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet, 2005; 366: 1267- 1278","DOI":"10.1016\/S0140-6736(05)67394-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Silverman MG, Ference BA, Im K, Wiviott SD, Giugliano RP, Grundy SM, Braunwald E, Sabatine MS: Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis. JAMA, 2016; 316: 1289-1297","DOI":"10.1001\/jama.2016.13985"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S, Committee for Epidemiology and Clinical Management of Atherosclerosis: Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. J Atheroscler Thromb, 2018; 25: 846-984","DOI":"10.5551\/jat.GL2017"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Fujiyoshi N, Arima H, Satoh A, Ojima T, Nishi N, Okuda N, Kadota A, Ohkubo T, Hozawa A, Nakaya N, Fujiyoshi A, Okamura T, Ueshima H, Okayama A, Miura K, NIPPON DATA2010 Research Group: Associations between socioeconomic status and the prevalence and treatment of hypercholesterolemia in a general Japanese population: NIPPON DATA2010. J Atheroscler Thromb, 2018; 25: 606-620","DOI":"10.5551\/jat.42531"},{"key":"5","unstructured":"5) European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D; ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees: ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J, 2011; 32: 1769-1818"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW; American College of Cardiology\/American Heart Association Task Force on Practice Guidelines: 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation, 2014; 129: S1-S45","DOI":"10.1161\/01.cir.0000437738.63853.7a"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Iso H: Lifestyle and cardiovascular disease in Japan. J Atheroscler Thromb, 2011; 18: 83-88","DOI":"10.5551\/jat.6866"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Iso H: A Japanese health success story: trends in cardiovascular diseases, their risk factors, and the contribution of public health and personalized approaches. EPMA J, 2011; 2: 49-57","DOI":"10.1007\/s13167-011-0067-0"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kitamura A, Sato S, Kiyama M, Imano H, Iso H, Okada T, Ohira T, Tanigawa T, Yamagishi K, Nakamura M, Konishi M, Shimamoto T, Iida M, Komachi Y: Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003: The Akita-Osaka Study. J Am Coll Cardiol, 2008; 52: 71-79","DOI":"10.1016\/j.jacc.2008.02.075"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Davis KL, Meyers J, Zhao Z, McCollam PL, Murakami M: High-risk atherosclerotic cardiovascular disease in a real-world employed Japanese population: prevalence, cardiovascular event rates, and costs. J Atheroscler Thromb, 2015; 22: 1287-1304","DOI":"10.5551\/jat.28852"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Goto A, Goto M, Noda M, Tsugane S. Incidence of type 2 diabetes in Japan: a systematic review and meta-analysis. PLoS One, 2013; 8: e74699","DOI":"10.1371\/journal.pone.0074699"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12) Nakamura M, Uno K, Hirayama A, Ako J, Nohara A, Arai H, Harada-Shiba M: Exploration into lipid manage ment and persistent risk in patients hospitalised for acute coronary syndrome in Japan (EXPLORE-J): protocol for a prospective observational study. BMJ Open, 2017; 7: e014427. doi:10.1136\/bmjopen-2016-014427","DOI":"10.1136\/bmjopen-2016-014427"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation, 2004; 110: 227-239","DOI":"10.1161\/01.CIR.0000133317.49796.0E"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Nishimura K, Okamura T, Watanabe M, Nakai M, Takegami M, Higashiyama A, Kokubo Y, Okayama A, Miyamoto Y: Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the Framingham risk score: the Suita study. J Atheroscler Thromb, 2014; 21: 784-798","DOI":"10.5551\/jat.19356"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Miyauchi K, Morino Y, Tsukahara K, Origasa H, Daida H; PACIFIC steering committee members: The PACIFIC (Prevention of AtherothrombotiC Incidents Following Ischemic Coronary attack) Registry: Rationale and design of a 2-year study in patients initially hospitalised with acute coronary syndrome in Japan. Cardiovasc Drugs Ther, 2010; 24: 77-83","DOI":"10.1007\/s10557-010-6223-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Tani S, Yagi T, Atsumi W, Kawauchi K, Matsuo R, Hirayama A: Relation between low-density lipoprotein cholesterol\/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study. Cardiovasc Diabetol, 2017; 16: 123","DOI":"10.1186\/s12933-017-0606-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Matsuzawa Y: Specific health guidance, the nationwide lifestyle intervention program targeting metabolic syndrome, seems to be successful in Japan. J Atheroscler Thromb, 2018; 25: 304-305","DOI":"10.5551\/jat.ED092"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Tsushita K, S Hosler A, Miura K, Ito Y, Fukuda T, Kitamura A, Tatara K: Rationale and descriptive analysis of specific health guidance: the nationwide lifestyle intervention program targeting metabolic syndrome in Japan. J Atheroscler Thromb, 2018; 25: 308-322","DOI":"10.5551\/jat.42010"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Howard BV, Roman MJ, Devereux RB, Fleg JL, Galloway JM, Henderson JA, Howard WJ, Lee ET, Mete M, Poolaw B, Ratner RE, Russell M, Silverman A, Stylianou M, Umans JG, Wang W, Weir MR, Weissman NJ, Wilson C, Yeh F, Zhu J: Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA, 2008; 299: 1678-1689","DOI":"10.1097\/01.ogx.0000320471.93857.21"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Arnold SV, Kosiborod M, Tang F, Zhao Z, McCollam PL, Birt J, Spertus JA: Changes in low-density lipoprotein cholesterol levels after discharge for acute myocardial infarction in a real-world patient population. Am J Epidemiol, 2014; 179: 1293-1300","DOI":"10.1093\/aje\/kwu060"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/26\/6\/26_45583\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T12:49:01Z","timestamp":1662554941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/26\/6\/26_45583\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.45583","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,1]]}}}